Advertisement
Screener

BIOTECH ACQUISITION COMPANY Debt Instrument, Convertible, Conversion Price

BIOTECH ACQUISITION COMPANY Debt Instrument, Convertible, Conversion Price

BIOTECH ACQUISITION COMPANY had Debt Instrument, Convertible, Conversion Price of $1.00 per share as of 2022-09-30, per its 10-Q filed 2022-11-22.

Discontinued › Notes › Debt › Debt Instruments

us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2022-11-22

  • 2022-09-30: Debt Instrument, Convertible, Conversion Price $1.00.
  • 2022-06-30: Debt Instrument, Convertible, Conversion Price $1.00.
  • 2022-03-31: Debt Instrument, Convertible, Conversion Price $1.00.
  • 2021-12-31: Debt Instrument, Convertible, Conversion Price $1.00.
Period endDebt Instrument, Convertible, Conversion Price
2022-09-30$1.00
10-Q · filed 2022-11-22
2022-06-30$1.00
10-Q · filed 2022-08-22
2022-03-31$1.00
10-Q · filed 2022-05-16
2021-12-31$1.00
10-K · filed 2022-03-08
2021-09-30$1.00
10-Q · filed 2021-11-17
2021-06-30$1.00
10-Q · filed 2021-08-11
2021-03-31$1.00
10-Q · filed 2021-05-24
2020-12-31$1.00
10-K · filed 2021-03-23
2020-09-30$1.00
10-Q · filed 2021-03-11